LENSAR, Inc. LNSR
Nasdaq · XNAS · stock · Surgical & Medical Instruments & Apparatus
Chart by TradingView
2/9
Piotroski F — financial health
-10.17
Altman Z″ — distress risk · distress
—
Dividend payout · no dividend
Financials (annual, from 10-K)
| FY | Revenue | Net income | Gross profit | Free cash flow | Equity |
|---|---|---|---|---|---|
| 2025 | $51.7M | -$34.3M | — | -$14.9M | -$26.0M |
| 2024 | $46.0M | -$31.4M | — | -$2.4M | $4.9M |
| 2023 | $42.2M | -$14.4M | — | -$9.9M | $33.4M |
| 2022 | $29.4M | -$19.9M | — | -$15.0M | $42.0M |
| 2021 | $34.5M | -$19.6M | — | -$9.3M | $54.9M |
| 2020 | $22.8M | -$19.8M | — | -$14.2M | $67.2M |
Recent insider activity (Form 4)
| Insider | Role | Date | Action | Shares | Price |
|---|---|---|---|---|---|
| HAMMER TODD B | director | 2026-06-03 | Grant | 17,421 | — |
| ELLIS THOMAS B | director | 2026-06-03 | Grant | 17,421 | — |
| Wong Kendra | Principal Accounting Officer | 2026-06-03 | Grant | 13,066 | — |
| Connaughton Alan B. | Chief Operating Officer | 2026-06-03 | Grant | 34,843 | — |
| CURTIS NICHOLAS T | Chief Executive Officer | 2026-06-03 | Grant | 130,662 | — |
| WEISNER AIMEE S | director | 2026-06-03 | Grant | 17,421 | — |
| O'Farrell Elizabeth G. | director | 2026-06-03 | Grant | 17,421 | — |
| Winer Gary M | director | 2026-06-03 | Grant | 17,421 | — |
Why these scores methodology →
Piotroski F-score: 2/9
- Positive return on assets
- Positive operating cash flow
- Rising ROA
- Cash flow exceeds net income
- Lower long-term debt
- Rising current ratio
- No share dilution
- Rising gross margin
- Rising asset turnover
Altman Z″: -10.17 (distress)
- Working capital / assets 0.087
- Retained earnings / assets -2.486
- EBIT / assets -0.344
- Equity / liabilities -0.311
Source: SEC EDGAR filings · CIK 0001320350 · as of 2025-12-31. Figures are facts from filings plus Stocktoria's own computed scores — not investment advice.